KARCIOĞLU, A. M. Et Al. 2018. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.4 , 254-260.

KARCIOĞLU, A. M., OKAY, M., BÜYÜKAŞIK, Y., Malkan, Ü. Y., SAYINALP, N., DEMİROĞLU, H., ... GÖKER, H.(2018). Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.4, 254-260.

KARCIOĞLU, AYŞE Et Al. "Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.4, 254-260, 2018

KARCIOĞLU, AYŞE M. Et Al. "Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.4, pp.254-260, 2018

KARCIOĞLU, A. M. Et Al. (2018) . "Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.28, no.4, pp.254-260.

@article{article, author={AYŞE MÜGE KARCIOĞLU Et Al. }, title={Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2018, pages={254-260} }